Page last updated: 2024-12-10
pyrethrosin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
pyrethrosin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5281496 |
CHEBI ID | 8661 |
SCHEMBL ID | 5188143 |
MeSH ID | M0044245 |
Synonyms (15)
Synonym |
---|
germacra-4,11(13)-dien-12-oic acid, 1-beta,10-epoxy-6-alpha,8-alpha-dihydroxy-, 12,8-lactone, acetate, (e)- |
oxireno(8,9)cyclodeca(1,2-b)furan-8(2h)-one, 6-(acetyloxy)-1a,3,6,6a,7,9a,10,10a-octahydro-4,10a-dimethyl-7-methylene-, (1ar-(1ar*,4e,6r*,6ar*,9as*,10ar*))- |
ai3-31868 |
germacra-4,11(13)-dien-12-oic acid, 1alpha,10alpha-epoxy-6,8beta-dihydroxy-, 12,8-lactone, acetate |
nsc 22070 |
pyrethrosin |
chebi:8661 , |
z13ox0769a , |
unii-z13ox0769a |
SCHEMBL5188143 |
pyrethrosin [mi] |
germacra-4,11(13)-dien-12-oic acid, 1.beta.,10-epoxy-6.alpha.,8.alpha.-dihydroxy-, 12,8-lactone, acetate, (e)- |
[(1s,3r,5r,8e,10r,11r)-3,8-dimethyl-12-methylidene-13-oxo-4,14-dioxatricyclo[9.3.0.03,5]tetradec-8-en-10-yl] acetate |
Q27108132 |
DTXSID701018639 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
Class | Description |
---|---|
gamma-lactone | A lactone having a five-membered lactone ring. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID357590 | Antifungal activity against Candida albicans | 2001 | Journal of natural products, Aug, Volume: 64, Issue:8 | Microbial transformation of pyrethrosin. |
AID357588 | Cytotoxicity against human SK-MEL cells | 2001 | Journal of natural products, Aug, Volume: 64, Issue:8 | Microbial transformation of pyrethrosin. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 44.65
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (44.65) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |